Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity

1. Jiménez-Solas, T.
2. López-Cadenas, F.
3. Aires-Mejía, I.
4. Caballero-Berrocal, J.C.
5. Ortega, R.
6. Redondo, A.M.
7. Sánchez-Guijo, F.
8. Muntión, S.
9. García-Martín, L.
10. Albarrán, B.
11. Alonso, J.M.
12. Del Cañizo, C.
13. Hernández-Hernández, Á.
14. Díez-Campelo, M.